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Nupr1/Chop signal axis is involved in
mitochondrion-related endothelial cell apoptosis
induced by methamphetamine
D Cai1, E Huang1, B Luo1, Y Yang1, F Zhang2, C Liu3, Z Lin4, W-B Xie*,1 and H Wang*,1
Methamphetamine (METH) abuse has been a serious global public health problem for decades. Previous studies have shown that
METH causes detrimental effects on the nervous and cardiovascular systems. METH-induced cardiovascular toxicity has been, in
part, attributed to its destructive effect on vascular endothelial cells. However, the underlying mechanism of METH-caused
endothelium disruption has not been investigated systematically. In this study, we identified a novel pathway involved in
endothelial cell apoptosis induced by METH. We demonstrated that exposure to METH caused mitochondrial apoptosis in human
umbilical vein endothelial cells and rat cardiac microvascular endothelial cells in vitro as well as in rat cardiac endothelial cells
in vivo. We found that METH mediated endothelial cell apoptosis through Nupr1–Chop/P53–PUMA/Beclin1 signaling pathway.
Specifically, METH exposure increased the expression of Nupr1, Chop, P53 and PUMA. Elevated p53 expression raised up PUMA
expression, which initiated mitochondrial apoptosis by downregulating antiapoptotic Bcl-2, followed by upregulation of
proapoptotic Bax, resulting in translocation of cytochrome c (cyto c), an apoptogenic factor, from the mitochondria to cytoplasm
and activation of caspase-dependent pathways. Interestingly, increased Beclin1, upregulated by Chop, formed a ternary complex
with Bcl-2, thereby decreasing the dissociative Bcl-2. As a result, the ratio of dissociative Bcl-2 to Bax was also significantly
decreased, which led to translocation of cyto c and initiated more drastic apoptosis. These findings were supported by data
showing METH-induced apoptosis was significantly inhibited by silencing Nupr1, Chop or P53, or by PUMA or Beclin1 knockdown.
Based on the present data, a novel mechanistic model of METH-induced endothelial cell toxicity is proposed. Collectively, these
results highlight that the Nupr1–Chop/P53–PUMA/Beclin1 pathway is essential for mitochondrion-related METH-induced
endothelial cell apoptosis and may be a potential therapeutic target for METH-caused cardiovascular toxicity. Future studies using
knockout animal models are warranted to substantiate the present findings.
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Methamphetamine (METH) is a widely used addictive
stimulant with high potential of abuse. METH exposure
damages both the nervous and cardiovascular systems.1–5
In particular, METH has been associated with a myriad of
adverse effects on the circulatory system, including cardio-
myopathy, hypertension, arrhythmia, myocardial ischemia,
acute coronary syndrome, cardiac failure and sudden
death.6–8 In METH abusers with acute aortic dissection or
coronary syndrome, vascular structural alterations have been
found in the myocardium in a number of clinical cases,
indicating that METH can cause toxic effects on the blood
vessels.9,10 The above studies suggest that vascular endothe-
lial cells may be a key target in METH-caused cardiovascular
pathophysiologic alterations. Recent studies have shown that
METH exposure causes endothelial cell apoptosis,11–13 but
the underlying mechanisms remain to be elucidated.
Endoplasmic reticulum stress (ERS) pathway is a classical
apoptotic pathway following the discovery of death receptor
signaling and mitochondrial pathways.14,15 In the present
study, we hypothesized that Chop (as an ERS marker protein)
is involved in endothelial cell apoptosis induced by METH.
Chop (encoded by the DDIT3 gene), is the key apoptosis
inducer in the proteotoxic stress response.16,17 Chop has
been shown to be pro- and antiapoptotic depending on cell
and stress context.18 Increased expression of theDDIT3 gene
or microinjections of the Chop protein led to dissipation of the
mitochondrial transmembrane potential (MMP), generation of
reactive oxygen species and apoptotic cell death.19
Recently, it was reported that increased expression of Chop
and induction of apoptosis in response to ERS can be directly
induced by nuclear protein 1 (Nupr1) in PANC-1 human
pancreatic carcinoma cells.20,21 It is known that Nupr1 (also
1Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China; 2Key Lab of Forensic Pathology, Guangdong
Provincial Public Security Department, Guangzhou 510050, China; 3Guangzhou Forensic Science Institute, Guangzhou 510030, China and 4Department of Anatomy and
Physiology, College of Veterinary Medicine, Institute of Computational Comparative Medicine, Kansas State University, Manhattan, KS 66506, USA
*Corresponding author: W-B Xie or H Wang, Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, 1023# South Shatai Road,
Guangzhou 510515, People’s Republic of China. Tel: +86 20 62789044; Fax: +86 20 61648359; E-mail: xieweib@126.com or hjwang711@yahoo.cn
Received 16.11.15; revised 31.1.16; accepted 22.2.16; Edited by C Munoz-Pinedo
Abbreviations: BBB, blood–brain barrier; CMECs, cardiac microvascular endothelial cells; cyto c, cytochrome c; CHOP, C/EBP homologous protein; ERS, endoplasmic
reticulum stress; FBS, fetal bovine serum; HUVECs, human umbilical vein endothelial cells; METH, methamphetamine; MMP, mitochondrial transmembrane potential;
PERK, PKR-like endoplasmic reticulum kinase; PUMA, p53 upregulated modulator of apoptosis; Nupr1, nuclear protein 1; TUNEL, terminal deoxynucleotidyl transferase
(TdT)-mediated UTP nick end labeling
Citation: Cell Death and Disease (2016) 7, e2161; doi:10.1038/cddis.2016.67
& 2016 Macmillan Publishers Limited All rights reserved 2041-4889/16
www.nature.com/cddis
named as p8 or com1) expression is upregulated in response
to stress and thus influenced by the host microenvironment.
Decreased Nupr1 expression is accompanied by suppression
of cancer cell growth in vitro and in vivo.22,23 However,
increased Nupr1 mRNA also accompanies apoptotic changes
in cancer cells.24 While Nupr1 gene expression is induced in
response to a variety of stress factors, DDIT3 gene is
specifically related to the ERS response.25
The objective of this study was to investigate the role of ERS
and Nupr1 in METH-caused apoptosis in vascular endothelial
cells. We determined METH-induced changes of Nupr1
expression and cellular apoptosis level in vitro using human
umbilical vein endothelial cells (HUVECs) and rat cardiac
microvascular endothelial cells (CMECs), as well as in vivo
using vascular endothelium from Sprague–Dawley rats
exposed to METH. Our results indicate that ERS induced by
Nupr1 plays a crucial role in METH-induced vascular
endothelial cell apoptosis and the Nupr1–Chop/P53–PUMA/
Beclin1 pathway may be a potential therapeutic target of
METH-induced cardiovascular toxicity.
Results
METH induces Nupr1 protein expression in vascular
endothelial cells in vivo and in vitro. To assess the role of
Nupr1 in the METH-induced endothelial cell toxicity, HUVECs
were exposed to 1.25 mM METH and then western blot
analysis was performed to detect the expression of Nupr1.
Our results revealed that Nupr1 expression was significantly
increased (Figures 1a and b) in the METH-treated HUVECs
than in the control. Cleaved-caspase-3 and cleaved-PARP
(Figures 1a and b) were also significantly increased in the
METH-treated HUVECs. Similar effects were observed in
CMECs after METH (0.5 mM) exposure for 24 h (Figures 1c
and d).
Furthermore, a rat model treated with METH (8 injections,
15 mg/kg/injection, at 12 h intervals) was used to ascertain
whether METH induces Nupr1 expression and vascular
endothelial cell apoptosis in vivo. Immunofluorescence stain-
ing results showed that METH treatment increased Nupr1
expression in rat cardiac microvascular endothelial tissues
(Figure 1e). Apoptotic cells (labeled with arrows) in cardiac
microvascular endothelial tissues were observed with TUNEL
(terminal deoxynucleotidyl transferase (TdT)-mediated UTP
nick end labeling) staining (Figure 1f). The results demon-
strated that METH treatment caused microvascular endo-
thelial cell apoptosis in rat cardiac tissues. Additionally, flow
cytometry analyses showed that METH induced HUVECs and
CMECs' apoptosis time dependently (Supplementary Figures
S1a and b). These results suggest that METH exposure
induces Nupr1 expression and endothelial cells' apoptosis
both in vivo and in vitro.
Nupr1 is necessary for METH-induced apoptosis in
HUVECs and CMECs. To examine whether Nupr1 is
involved in the process of METH-induced apoptosis, we
used siRNAs targeting Nupr1 to silence Nupr1 expression
and then examined the effects on METH-caused apoptosis in
HUVECs. Western blot analysis showed that both of two
siRNAs can effectively knockdown Nupr1 expression
(Figures 2a and b). Next, we evaluated whether silencing of
Nupr1 by siRNAs also reduces METH-induced apoptosis
in vitro. Western blot results showed that cleaved-caspase-3
and cleaved-PARP protein levels were decreased after Nupr1
knockdown in HUVECs (Figures 2a and b). Similar effects
were observed in CMECs (Figures 2c and d).
To confirm that silence of Nupr1 protects against
METH-induced apoptosis, TUNEL staining was performed
(Figures 2e and f for HUVECs; Figures 2g and h for CMECs).
These results suggest that blockade of Nupr1 expression
reduces METH-induced apoptosis in HUVECs and CMECs,
indicating that Nupr1 is involved in METH-induced apoptosis
in vitro. To further evaluate the effect of Nupr1 on METH-
caused toxicity, we investigated whether Nupr1 expression
blockade affects apoptosis induced by METH in endothelial
cells using flow cytometry analysis. Silence of Nupr1
significantly reduced the percentage of apoptotic cells caused
by METH (Figures 2i and j). Similar results were obtained from
CMECs (Figures 2k and l).
Nupr1 mediates METH-induced endothelial cell apopto-
sis through the classical mitochondrial apoptotic signal-
ing pathways. To determine whether Nupr1 is involved in
the mitochondria-dependent apoptosis induced by METH in
endothelial cells, we examined the change of Bax and Bcl-2
expression level with and without Nupr1 knockdown. Western
blot results showed that the expression level of Bax, a
proapoptotic factor, was increased after exposure to METH
for 24 h, and decreased following Nupr1 knockdown in
HUVECs (Figures 3a and b), while the expression level of
Bcl-2, an antiapoptotic factor, was decreased after exposure
to METH for 24 h, and increased following Nupr1 knockdown
in HUVECs (Figures 3a and c). The balance between
proapoptotic proteins (e.g., Bax) and antiapoptotic proteins
(e.g., Bcl-2) of Bcl family plays a key role in regulation of
intrinsic pathway of cell apoptosis. In fact, the ratio of Bax/
Bcl-2 was increased in METH-treated group compared with
the ctrl group and decreased after Nupr1 was knocked down
(Figure 3d). Similar results were observed in CMECs
(Figures 3i–l).
We found that the cyto c protein level in cytoplasmic fraction
was increased significantly when exposed to METH, while
mitochondrial fraction was reduced significantly in HUVECs.
This phenomenon was restrained after Nupr1 knockdown
(Figures 3e–h). Similar results were obtained from CMECs
(Figures 3m–p). Taken together, these results indicate that
downregulation of Nupr1 inhibits the mitochondria-mediated
apoptotic pathway induced by METH.
Chop is involved in Nupr1-mediated apoptosis in METH-
exposed endothelial cells. Chop, a transcription factor, is a
key mediator of cell death in response to ERS. In the present
study, we found that Chop protein expression was increased
in both HUVECs (Figures 4a and b) and CMECs (Figures 4c
and d) after METH exposure. Increased expression of
Chop and induction of apoptosis in response to ERS have
been associated with Nupr1 activation in astrocytoma
cells exposed to cannabinoid,26 so we assessed the effect
on Chop expression after silencing Nupr1. We observed that
Nupr1/Chop and METH-induced EC apoptosis
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Chop expression was decreased following Nupr1 expression
knockdown in METH-treated HUVECs (Figures 4e and f) and
CMECs (Figures 4g and h).
Next, we examined whether Chop is involved in METH-
induced apoptosis. We found that METH exposure induced
Chop expression in the ctrl siRNA group; this effect was
significantly attenuated by co-exposure to either of the siChop
sequences (Figures 4i and j). The expression level of cleaved-
caspase-3 and cleaved-PARP were decreased following
Chop knockdown in HUVECs (Figures 4i and j). However,
the expression of Nupr1 showed no difference, indicating that
Chop does not regulate Nupr1 (Figures 4i and j). Similar
effectswere observed in CMECs (Supplementary Figures S2a
and c). Additionally, we observed that Bax was increased after
METH treatment and decreased following Chop knockdown
in CMECs (Supplementary Figures S2a and d), while the
expression level of Bcl-2 was decreased after METH exposure
and increased following Chop knockdown in CMECs
(Supplementary Figures S2a and e). The ratio of Bax/Bcl-2
was increased in the METH-treated group compared with the
ctrl group and decreased after Chop knock down in CMECs
(Supplementary Figure S2f).
We also investigated whether the Chop expression block-
ade affects METH-induced apoptosis in HUVECs using flow
cytometry analysis (Figures 4k and l) and TUNEL staining
(Figures 4m and n). These results indicate that the blockade of
Chop expression also inhibits endothelial cells’ apoptosis
induced by METH.
Nupr1/Chop/P53 axis is involved in classical mitochon-
drial apoptosis caused by METH in endothelial cells. The
downstream targets of Chop in Nupr1–Chop axis-mediated
METH-induced endothelia cell apoptosis have not been
identified. Among many downstream targets of Chop, the
P53 protein is a key regulator of cell cycle, apoptosis, DNA
repair and senescence.27,28 Next, we evaluated the role of
p53 in METH-induced endothelial cell apoptosis. We found
that METH exposure increased P53 expression significantly
in both HUVECs (Figures 5a and b) and CMECs (Supple-
mentary Figures S3a and b). P53 expression was decreased
following Nupr1 or Chop knockdown in METH-treated
HUVECs, suggesting that P53 is regulated by Nupr1 and
Chop in HUVECs (Figures 5c–f). We also observed this
phenomenon in METH-treated CMECs (Supplementary
Figure 1 Nupr1 expression is upregulated in endothelial cells after METH exposure in vitro and in vivo. (a) HUVECs were exposed to 1.25 mM METH for indicated times
(0, 12, 24, 36 and 48 h). (c) CMECs were exposed to METH (0.5 mM) for 24 h. The protein expression of Nupr1, cleaved-PARP and cleaved-caspase-3 was determined with
western blot (a and c) and quantitative analyses (b and d). Fold induction relative to cells treated with vehicle is shown. β-Actin was used as a loading control. *Po0.05 versus
vehicle-treated cells. Data were analyzed with one-way ANOVA followed by LSD post hoc comparisons. Data represent mean± S.D. (n= 3 replicates). (e and f) Male SD rats
(n= 5/group) were injected i.p. with saline or METH (15 mg/kg × 8 injections, at 12 h interval). The heart tissues were harvested at 24 h after the last dosing. Immunolabeling and
confocal imaging analysis (e) showed elevated Nupr1 expression in the heart microvascular endothelial cells of METH-exposed rats compared with controls (Ctrl). TUNEL
staining and confocal imaging analysis (f) was used to evaluate the endothelial cell apoptosis. Apoptotic cells were stained with TUNEL (Red). Nuclei were counterstained with
DAPI (blue) and BF represents bright field
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Figures S3c–f), which indicates that P53 is the downstream
protein of Nupr1 and Chop. On the other hand, Nupr1 and
Chop expression did not change following P53 knockdown in
METH-treated HUVECs (Figures 5g and h) and CMECs
(Supplementary Figures S3g and h), suggesting that both
Nupr1 and Chop is not regulated by p53. Instead, Nupr1
regulates P53 in METH-treated HUVECs and CMECs.
Furthermore, we found that cleaved-caspase-3 and
cleaved-PARP protein levels were decreased following P53
expression knockdown in HUVECs (Figures 5g and h)
and CMECs (Supplementary Figures S3g and h). The
expression level of Bax was increased after METH exposure
and decreased following P53 knockdown, while Bcl-2 was
decreased after METH exposure and increased following
P53 knockdown in HUVECs (Figures 5g, i and j) and CMECs
(Supplementary Figures S3g, i and j). The ratio of Bax/Bcl-2
was increased in METH-treated group compared with the ctrl
group and decreased after P53 knockdown in HUVECs
(Figure 5k) and CMECs (Supplementary Figure S3k).
We also found that cyto c protein was translocated from
mitochondria to cytoplasm and that the translocation was
reversed by silence of P53 in HUVECs (Figures 5l–o) and
CMECs (Supplementary Figures 3l–o). Taken together, these
results indicate that P53 is involved in Nupr1–Chop axis-
mediated METH-induced mitochondrial apoptosis in
endothelial cells.
Figure 2 Nupr1 is necessary for METH-induced apoptosis in HUVECs and CMECs. (a) Synthetic Nupr1 siRNAs effectively suppressed endogenous Nupr1 expression on
HUVECs. HUVECs were transfected with siRNAs targeting Nupr1 or control siRNA for 48 h followed by METH (1.25 mM) treatment for 24 h. (c) Lentivrus-mediated Nupr1
shRNAs effectively suppressed endogenous Nupr1 expression in CMECs. CMECs were incubated with viral supernatants for 24 h followed by METH (0.5 mM) treatment for
another 24 h. Western blot (a and c) and quantitative analyses were performed to evaluate the efficiency of Nupr1 knockdown (b and d), and the expression of apoptosis-related
proteins (cleaved-PARP (Cl-PARP) and cleaved-caspase-3 (Cl-casp3)) after knocking down Nupr1 expression in HUVECs (b) and CMECs (d). Effects of suppressing Nupr1
expression on the apoptosis caused by 1.25 mM METH in HUVECs and by 0.5 mM METH in CMECs were assessed with TUNEL (e: green for HUVECs; g: red for CMECs) and
flow cytometry ((i) HUVECs and (k) CMECs). (f and h) Quantitative analysis of the percentage of apoptotic cells using a standard cell counting method with the TUNEL assay.
Apoptotic cells were stained with TUNEL (green for HUVECs (f) and red for CMECs (h)). Nuclei were counterstained with DAPI (blue). (j and l) Quantitative analysis of the effects
of knocking down Nupr1 on apoptosis induced by METH using flow cytometry. Representative calculations from three independent replicates are shown. The percentage of
apoptotic cells is presented as mean± S.D. (n= 3, *Po0.01 versus the saline vehicle-treated control group; **Po0.01 versus the scrambled+METH group; one-way ANOVA)
Nupr1/Chop and METH-induced EC apoptosis
D Cai et al
4
Cell Death and Disease
PUMA is the initiator in the Nupr1/Chop axis-activated
classical mitochondrial apoptotic signaling pathways in
METH-exposed endothelial cells. Previous studies have
demonstrated that PUMA induces apoptosis in part by
displacing Bax from Bcl-XL, thereby promoting the multi-
merization and mitochondrial translocation of Bax.29–31 To
assess the role of PUMA in the METH-induced toxicity,
HUVECs were treated with METH and then western blot
analysis was performed to detect PUMA expression. The
results showed that PUMA expression was significantly
increased by METH exposure (Supplementary Figure S4a).
Similar effects were observed in CMECs (Supplementary
Figure 4b). Next, we studied the effect of Nupr1 knockdown
on the increased expression of PUMA caused by METH. We
found that PUMA expression was decreased following Nupr1
knockdown in METH-treated HUVECs, suggesting that
PUMA is regulated by Nupr1 (Figures 6a and b). We also
observed that PUMA expression was reduced after Chop
knockdown in METH-treated HUVECs (Figures 6c and d),
which indicates that PUMA is the downstream protein of
Chop. In addition, we observed that PUMA expression was
decreased following P53 knockdown in METH-exposed
HUVECs (Figures 5g and h) and CMECs (Supplementary
Figures S3g and h), suggesting that PUMA is downstream
target of P53. As demonstrated previously, Chop was
regulated by Nupr1 in METH-treated HUVECs (Figures 4e
and f) and CMECs (Figures 4g and h), and P53 was
regulated by Nupr1 and Chop in METH-treated HUVECs
Figure 3 Nupr1 mediates METH-induced apoptosis through the classical mitochondrial apoptotic signaling pathways. (a and e) HUVECs were transfected with siRNAs
targeting Nupr1 or control siRNA for 48 h followed by METH (1.25 mM) treatment for 24 h. (i andm) CMECs were incubated with LV-shRNA or LV-GFP control viral supernatants
for 24 h followed by METH (0.5 mM) treatment for 24 h. The protein levels of Bax (b and j), Bcl-2 (c and k), cytosolic cyto c (cyto cyt-c; f and n), and mitochondrial cyto c (mit cyt-c;
g and o) were measured using western blot analyses. The Bax/Bcl-2 (d and l) and cyto cyt-c/mit cyt-c (h and p) ratios were calculated. Data are presented as mean ± S.D.
(n= 3). *Po0.01 versus the saline vehicle-treated ctrl group, **Po0.01 versus the scrambled+METH group (one-way ANOVA)
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Figure 4 Chop is involved in Nupr1-mediated apoptosis in METH-exposed endothelial cells. (a) HUVECs were exposed to 1.25 mM METH for indicated time (0, 12, 24, 36
and 48 h). (c) CMECs were exposed to METH (0.5 mM) for 24 h. (e) HUVECs were transfected with siRNAs targeting Nupr1 or ctrl siRNA for 48 h followed by METH (1.25 mM)
treatment for 24 h. (g) CMECs were incubated with LV-shNupr1 or LV-GFP control viral supernatants for 24 h followed by METH (0.5 mM) treatment for 24 h. (i) HUVECs were
transfected with siRNAs targeting Chop or ctrl siRNA for 48 h followed by METH (1.25 mM) treatment for 24 h. Western blot (a, c, e, g, i) and quantitative analyses (b, d, f, h and j)
were performed to evaluate the expression of Chop, Nupr1, cleaved-PARP (Cl-PARP) and cleaved-caspase-3 (Cl-casp3). Effects of suppressing Chop expression on 1.25 mM
METH-treated HUVECs were assessed by flow cytometry (k and l) and TUNEL (m and n). Apoptotic cells were stained with TUNEL (green). Nuclei were counterstained with
DAPI (blue). (l) Quantitative analysis of the effects of Chop knockdown on apoptosis induced by METH using flow cytometry. (n) Quantitative analysis of the percentage of
apoptotic cells using a standard cell counting method with the TUNEL assay. Representative calculations from three independent experiments are shown. The rate of apoptosis is
presented as mean± S.D. (n= 3, *Po0.01 versus the saline vehicle-treated ctrl group, **Po0.01 versus the scrambled+METH group, one-way ANOVA)
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Figure 5 P53 is involved in Nupr1–Chop axis-mediated mitochondrial apoptotic signaling pathways caused by METH in endothelial cells. (a) HUVECs were exposed to
METH (1.25 mM) for 24 h. (c, e and g) HUVECs were transfected with siRNAs targeting Nupr1 (c), Chop (e), P53 (g) or ctrl siRNA for 48 h followed by METH (1.25 mM)
treatment for 24 h. Western blot (a, c, e, g) and quantitative analyses (b, d, f and h–j) were performed to evaluate the expression of P53, Beclin1, Bax, Bcl-2, Chop, Nupr1,
cleaved-PARP (Cl-PARP) and cleaved-caspase-3 (Cl-casp3). The protein levels of cytosolic cyto c and mitochondrial cyto c (l–n) were measured using western blot analyses. The
Bax/Bcl-2 (k) and cyto cyt-c/mit cyt-c (o) ratios were calculated. Data are presented as mean ± S.D. (n= 3). *Po0.01 versus the saline vehicle-treated ctrl group, **Po0.01
versus the scrambled+METH group (one-way ANOVA)
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(Figures 5c–f) and CMECs (Supplementary Figures S3c–f).
Based on these results, we hypothesized that Nupr1 regu-
lates PUMA expression through Chop–P53 axis in METH-
induced apoptosis process.
To test this hypothesis, we investigated that if PUMA
is responsible for METH-induced apoptosis. Western blot
analysis showed that METH exposure induced PUMA
expression in the ctrl siRNA group and this effect was
Figure 6 PUMA is the initiator in the Nupr1/Chop axis-activated classical mitochondria apoptotic signaling pathways. HUVECs were transfected with siRNAs targeting Nupr1
(a), Chop (c), PUMA (e) or ctrl siRNA for 48 h followed by METH (1.25 mM) treatment for 24 h. Western blot (a, c, e, j) and quantitative analyses (b, d, f, g–i, k–m) were
performed to evaluate the expression of PUMA, Bax, Bcl-2, cleaved-PARP (Cl-PARP), cleaved-caspase-3 (Cl-casp3), the ratio of Bax/Bcl-2, cytosolic cyto c (cyt cyt-c),
mitochondrial cyto c (Mit cyt-c) and the Cyt cyt-c/Mit cyt-c ratio. (n) Mitochondrial membrane potential (MMP) was analyzed with fluorescent probe JC-1 assay. (o) Quantitative
results of JC-1 assay. Data are presented as mean± S.D. (n= 3). *Po0.05 versus the saline vehicle-treated control group and **Po0.05 versus the scrambled+METH group
(one-way ANOVA)
Nupr1/Chop and METH-induced EC apoptosis
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significantly attenuated by co-exposure to the siPUMA
sequence (Figures 6e and f). We found that Bax was
increased after 24 hMETH exposure, and decreased following
PUMA knockdown in HUVECs, while the expression level of
Bcl-2 showed opposite effects (Figures 6e, g and h). The
cytosolic cyto c protein level was increased significantly, while
mitochondrial cyto c was decreased significantly when
exposed to METH (Figures 6j–m). Together, these results
suggest that silencing of PUMA expression reduces METH-
induced apoptosis in HUVECs. Similar effects were observed
in CMECs (Supplementary Figure S5).
To confirm that silence of PUMA expression protects
against METH-induced apoptosis, we analyzed the changes
in the MMP using the JC-1 indicator, as an independent
method, to evaluate the induction of the proapoptotic process
in METH-treated HUVECs. It was found that the METH-
caused reduction of HUVEC viability was accompanied by a
reduction in the transmembrane potential in approximately
20% of the cells. However, this reduction was significantly
attenuated to 12% after PUMA knockdown (Figures 6n and o).
All of these results indicate that PUMA plays a key role in the
Nupr1/Chop axis-activated classical mitochondrial apoptotic
signaling pathways in METH-exposed endothelial cells.
Beclin1 promotes apoptosis by binding with Bcl-2 and
through the Nupr1/Chop axis-activated classical mito-
chondria apoptotic signaling pathways in METH-exposed
endothelial cell. Since Beclin1 is known to be involved in
the signal crosstalk between ERS and mitochondrial dysfunc-
tion, our next question was if METH-induced apoptosis is
mediated through Beclin1. We observed that Beclin1
expression was significantly increased after METH exposure
in HUVECs (Supplementary Figures S6a and a1) and
CMECs (Supplementary Figures S6b and b1). Notably,
we observed that Beclin1 expression was decreased after
Nupr1 knockdown in HUVECs (Figures 7a and b). These
results suggest that Beclin1 is regulated by Nupr1. Besides
Nupr1, we also observed that Beclin1 expression was
reduced following Chop knockdown in HUVECs (Figures 7c
and d) and in CMECs (Supplementary Figures S2a and b),
indicating that Beclin1 is also regulated by Chop. However,
our results showed that Beclin1 expression did not change
following P53 knockdown in METH-treated HUVECs
(Figures 5g and h) and CMECs (Supplementary Figures
S3g and h), indicating that Beclin1 is not a downstream target
of P53.
Previously, we demonstrated that Chop was regulated by
Nupr1 (Figures 4e–h). Consequently, we further hypothesized
that Nupr1 regulates Beclin1 expression through Chop in
METH-induced apoptosis. Western blot analysis showed that
METH exposure induced Beclin1 expression in the ctrl siRNA
group; this effect was significantly mitigated by co-treatment
with the siRNAs (Figures 7e and f). In addition, the expression
level of cleaved-caspase-3 and cleaved-PARP was increased
after METH exposure for 24 h, and decreased following
Beclin1 knockdown in HUVECs (Figures 7e and f) and
CMECs (Supplementary Figures S7a and b). We also
observed that cyto c was translocated from mitochondria
to cytoplasmic fraction after METH exposure in HUVECs
(Figures 7j–m) and CMECs (Supplementary Figures S7c–f).
Notably, silencing of Beclin1 expression had no effect on Bax
and Bcl-2 expression induced by METH (Figures 7e, g–i),
which indicates that Beclin1-mediated mitochondria-related
apoptosis is not through regulating the expression of Bax
and Bcl-2.
To confirm that silence of Beclin1 expression protects
against METH-induced apoptosis, we analyzed the changes
in the MMP using the JC-1 indicator. It was found that the
reduction in HUVECs cell viability caused by METH was
associated with a reduction in theMMP (Figures 7n and o).We
also investigated whether silencing Beclin1 expression affects
METH-induced apoptosis in HUVECs using flow cytometry
analysis (Figures 8a and b) and TUNEL staining (Figures 8c
and d). Silence of Beclin1 significantly reduced the percentage
of apoptotic cells caused by METH exposure. Collectively,
these results indicate that the blockade of Beclin1 expression
inhibits endothelial cells’ apoptosis induced by METH.
Since our results showed that Beclin1 mediated
mitochondria-related METH-induced apoptosis not through
regulating the protein expression of Bax and Bcl-2, we hypo-
thesized that Beclin1 might regular METH-induced apoptosis
by forming Bcl-2/Beclin1 complex. Next, we used the
co-immunoprecipitation technique to test the hypothesis. As
shown in Figures 8e and f, the interaction betweenBeclin1 and
Bcl-2 was detected in METH-exposed HUVECs (Figure 8e)
and CMECs (Figure 8f), suggesting that Beclin1 mediates
mitochondria-related apoptosis is through interacting with
Bcl-2, thereby decreasing the dissociative Bcl-2.
Discussion
Recent studies have demonstrated that METH can impair
the blood–brain barrier (BBB), suggesting that some of the
neurotoxic effects of METH could be due to disruption of BBB,
which includes vascular endothelial cells.32 In the present
study, we show that METH exposure induces apoptosis of
endothelial cells both in vitro and in vivo, which is consistent
with the previous studies.11,33 Furthermore, we for the first
time demonstrate that ERS plays an essential role in METH-
induced endothelial cell apoptosis and the Nupr1/Chop signal
axis regulates the interaction between ERS and METH-
caused mitochondria-depending apoptosis.
Nupr1 can regulate autophagy and apoptosis, and may be
relevant to cardiovascular pathologies and cancers.34 Intrigu-
ingly, Nupr1 seems to play a dual role in the control of cell fate.
Nupr1 has also been implicated in mediating cannabinoid-
induced apoptosis of tumor cells through upregulation of the
ERS-related genes ATF4, Chop and Trib3 (tribbles pseudo-
kinase 3). All these observations suggest that cell or tissue-
specific factorsmay determine the final role played by Nupr1 in
the control of cell fate.35 Here we report that Nupr1 mediates
cell apoptosis induced by METH in endothelial cells. In
addition, we identified Chop, a transcription factor of CCAAT/
enhancer binding protein homologous protein family, which is
strictly correlated with ERS and participates in ER-mediated
apoptosis,36 as the downstream of Nupr1.
Chop is a non-ER localized transcription factor that is
induced by a variety of adverse physiological conditions,
including ERS, and it is thought to be a critical mediator of
stress-induced apoptosis.37,38 Chop was shown to bind to the
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PUMA promoter during ERS and Chop knockdown attenuated
PUMA induction and neuronal apoptosis.39–42 Here, we
demonstrated that Chop increases the expression level of
PUMA through P53 to mediate apoptosis caused by METH
through the mitochondrial pathway, resulting in changes in the
mitochondrial membrane potential, promotion of cyto c
release and initiation of caspase cascades. Specifically,
following METH exposure, Chop increases the expression of
Bax and decreases the expression of Bcl-2, which leads to
an increased Bax/Bcl-2 ratio, thereby inducing the release of
Figure 7 Beclin1 promotes apoptosis through the Nupr1/Chop axis-activated classical mitochondria apoptotic signaling pathways. HUVECs were transfected with siRNAs
targeting Nupr1 (a), Chop (c), Beclin1 (e), or control siRNA for 48 h followed by METH (1.25 mM) treatment for 24 h. Western blot (a, c, e and j) and quantitative analyses (b, d, f
and g–i, k–m) were performed to evaluate the expression of Beclin1, cleaved-PARP (Cl-PARP), cleaved-caspase-3 (Cl-casp3), Bax, Bcl-2, Bax/Bcl-2 ratio, cytosolic cyto
c (Cyt cyt-c), mitochondrial cyto c (Mit cyt-c) and Cyt cyt-c/Mit cyt-c ratio. (n) Mitochondrial membrane potential (MMP) was analyzed with fluorescent probe JC-1 assay.
(o) Quantitative results of JC-1 assay. Data are presented as mean± S.D. (n= 3). *Po0.05 versus the saline vehicle-treated ctrl group and **Po0.05 versus the scrambled+
METH group (one-way ANOVA)
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cyto c to initiate caspase cascades. Of note, there are other
downstream targets of Chop, including Bim (BH3-only
protein). Further studies are needed to identify additional
proteins that play a role in the Nupr1–Chop axis-mediated
METH-induced endothelial cell apoptosis.
In our experiments, we showed that Beclin1 is involved
in the mitochondrial apoptosis caused by METH. Notably,
silencing of Beclin1 expression has no effect on Bax and
Bcl-2 expression induced by METH, which indicates that
Beclin1-mediated mitochondria-related apoptosis is not
through regulating the expression of Bax and Bcl-2. There is
no evidence that Beclin1 has another pathway to induce
apoptosis other than forming Bcl-2/Beclin1 complex, which
regulates both apoptosis and autophagy by controlling of
the threshold between cell survival and cell death. Our
co-immunoprecipitation results suggest that Beclin1 physi-
cally interacts with Bcl-2. Therefore, we conclude that Beclin1
mediates mitochondria-related apoptosis may be through
forming a ternary complex with Bcl-2, thereby decreasing
the dissociative Bcl-2. However, further experiments are
necessary to fully understand the role of the Bcl-2/Bcl-xL–
Beclin1 interaction in METH-induced apoptosis.43,44
In this study, we showed that apoptotic effect of METH on
vascular endothelial cells (HUVECs and CMECs) is mediated
by upregulation of the stress protein Nupr1. Moreover, we
provide evidence that Nupr1 upregulation also takes place
Figure 8 Beclin1 promotes apoptosis by physically interacting with Bcl-2. Effects of suppressing Beclin1 expression on the apoptosis caused by 1.25 mM METH in HUVECs
were assessed with flow cytometry (a) and TUNEL (c: green for HUVECs). (b) Quantitative analysis of the effects of knocking down Beclin1 on apoptosis induced by METH using
flow cytometry. (d) Quantitative analysis of the percentage of apoptotic cells using a standard cell counting method with the TUNEL assay. Nuclei were counterstained with DAPI
(blue). (e) Endogenous Bcl-2 co-immunoprecipitated with Beclin1. Cell lysates from METH-treated HUVECs were immunoprecipitated with Beclin1 antibody or normal IgG and
blotted with Bcl-2 antibody. (f) Endogenous Beclin1 co-immunoprecipitated with Bcl-2. Cell lysates from METH-treated CMECs were immunoprecipitated with Bcl-2 antibody or
normal IgG and blotted with Beclin1 antibody. Representative calculations from three independent replicates are shown. The percentage of apoptotic cells is presented as
mean±S.D. (n= 3, *Po0.01 versus the saline vehicle-treated control group; **Po0.01 versus the scrambled+METH group; one-way ANOVA)
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in vivo and this apoptotic effect is associated with increased
activation of the Nupr1-regulated apoptotic pathway through
Chop. As a transcription factor, Chop upregulates the
expression of P53, resulting in upregulation of PUMA, which
mediates mitochondrial apoptosis pathway by changing the
ratio of Bax/Bcl-2. Chop also increases the expression of
Beclin1, which forms Bcl-2/Beclin1 complex and regulates
apoptosis. A schematic depicting this novel mechanism of
METH-induced endothelial cell apoptosis is provided in
Figure 9. The underlying mechanisms about how Beclin1
interacts with Bcl-2 and regulates METH-induced apoptosis
need further research. These findings provide insights into the
molecular mechanisms of Nupr1-mediated METH-induced
apoptosis in endothelial cells. However, our findings are
mainly based on in vitro experimental results. Future studies
using knockout animal models are needed to substantiate the
present findings.
Materials and Methods
Animal protocol. Healthy adult male Sprague–Dawley (SD) rats (180–220 g,
6–8 weeks old) were purchased from Laboratory Animal Center of Southern
Medical University (Guangzhou, China). Animals were housed individually in tub
cages with food and water available ad libitum on a 12 h light/dark cycle. Animals
were acclimated to the animal facility for 1 week before experimentation. Rats were
divided randomly into two groups (n= 5 each group). METH (499% purity;
National Institutes for Food and Drug Control, Guangzhou, China) was dissolved in
0.9% physiological saline. The hyperthermia produced by METH was counteracted
using a cooling bath. Rats were injected intraperitoneally (i. p.) with saline or METH
(8 injections, 15 mg/kg/injection, at 12 h intervals). This exposure paradigm was
chosen based on our and other previous studies to mimic human METH abuse
because the measured concentrations of METH in the blood and brain of the
METH-treated rats at 1 h after the last injection were in the range of reported blood
levels in METH abusers.5,45–47 All animals survived throughout the study period.
Rats were killed at 24 h after the last injection. Hearts were isolated and stored at
− 86 °C or in 4% paraformaldehyde at 4 °C. All animal procedure was approved by
the Institutional Animal Care and Use Committee at the Southern Medical University
and in accordance with the latest National Institutes of Health Guide for the Care
and Use of Laboratory Animals.
Cell culture. HUVECs were obtained from the Cell Bank of Shanghai Institute
for Biological Science, Chinese Academy of Science and cultured in high glucose
DMEM medium containing 10% fetal bovine serum (FBS) (Gibco, Grand Island, NY,
USA). Cells were grown in a CO2 incubator at 37 °C, with 5% CO2 and 95% filtered
air. The cells were passaged every 2–3 days. Isolation and identification of rat
CMECs were performed as previously described,48,49 with some modifications.
Briefly, 2-week-old SD rats were anesthetized by pentobarbital injection. The heart
was removed from the rat under sterile condition and then the left ventricular was
isolated. After washing with PBS, the epicardium was removed and the remaining
myocardium was then minced. The minced tissue was immersed in 0.2%
collagenase in 37 °C for 10 min, and then 0.02% trypsin was added for another
10 min to digest the tissue. High glucose DMEM medium with 10% FBS was added
to stop digestion, and then the solution was filtered through a 100-μm nylon mesh to
remove the undigested tissue. The filtered solution was centrifuged, resuspended in
high glucose DMEM medium containing 20% FBS, 0.12% heparin, 1% endothelial
cell growth supplement (ECGS) (Sigma, St. Louis, MO, USA), 0.5% streptomycin/
penicillin solution (10 000U/ml; Invitrogen, New York, NY, USA) and then cells were
seeded on dishes. After 8 h incubation in the cell incubator, the supernatant was
discarded, and then the high glucose DMEM medium containing 20% FBS, 0.12%
heparin, 1% ECGS and 0.5% streptomycin/penicillin solution was added. Thereafter,
the medium was changed every 48 h and the cells were passaged when they
reached the exponential phase (70–80% confluence). CMECs were seeded in
coverslips and acetylated low-density lipoprotein (15 μg/mg) was added when the
cells reached about 80% confluence. After 8 h incubation, the coverslip was washed
with PBS and fixed with 4% paraformaldehyde solution. The antibodies for CD31
(mouse, 1:100; Santa Cruz, Dallas, TX, USA) and fluorescein (Cy3)-conjugated
rabbit anti-mouse IgG (1:50; DingGuo, Dalian, China) were used together with 4′,6′-
diamidino-2-phenylindole (DAPI) nuclear labeling. Incubation periods with blocking
buffer, primary antibody, and secondary antibody were 30 min at room temperature,
overnight at 4 °C and 1 h at room temperature, respectively. Microphotographs were
taken using a fluorescence microscopy (A1+/A1R+; Nikon, Tokyo, Japan). Confluent
CMECs displayed typical ‘flagstone’ morphology. The representative immunofluor-
escence image demonstrated that the purity of rat primary dissociated CMECs is
more than 95% (Supplementary Figure S8).
Western blot analysis. HUVECs and CMECs were seeded on six-well plates
at a density of 3 × 105/well. Cells were exposed to saline vehicle or METH (1.25 mM
for HUVECs and 0.5 mM for CMECs) for 24 h. These concentrations were selected
based on other METH in vitro toxicity studies11,50 and the LC25 of METH in
HUVECs and CMECs (Supplementary Table S1). After exposure to different time
points, HUVECs and CMECs were lysed in RIPA buffer (Sigma) at 4 °C for 30 min.
Cell lysates were stored at − 86 °C. The total protein concentration was determined
using the Bradford method. The samples were then separated with SDS-
polyacrylamide gel electrophoresis and electroblotted onto polyvinylidenedifluoride
membranes. After blocking with TBST-buffered saline solution containing 5% dry
milk for 1.5 h, the membranes were incubated overnight at 4 °C or at 25 °C for 2 h
with primary antibodies, including rabbit polyclonal anti-Nupr1 (1:1000; BioVision,
Milpitas, CA, USA), rabbit polyclonal anti-Chop, rabbit polyclonal anti-Beclin1, rabbit
polyclonal anti-Puma, rabbit polyclonal anti-Bax, rabbit polyclonal anti-Bcl-2, rabbit
polyclonal anti-cyto c, rabbit polyclonal anti-caspase-3, rabbit polyclonal anti-PARP
(all in 1:1000 and from the Cell Signaling Technology, Danvers, MA, USA), rabbit
P53 (1:500; ABclonal Biotech Co., Ltd, College Park, MD, USA) and rabbit
polyclonal anti-β-actin (1:2000; Cell Signaling Technology). Thereafter, membranes
were incubated with corresponding horseradish peroxidase-conjugated secondary
antibodies at 25 °C for 1 h. Membranes were developed with Chemiluminescence
ECLPlus western blotting detection reagents. Proteins of interest were quantified
based on pixel density with the Gel-Pro analyzer software (Media Cybernetics, Inc.,
Rockville, MD, USA) and then normalized to a correspondent β-actin loading control
prior to statistical analyses.
Annexin V apoptosis staining. HUVECs and CMECs were seeded on
six-well plates at a density of 2 × 106/well. Cells were exposed to saline vehicle or
Figure 9 A schematic depicting the role of Nupr1–Chop/P53–PUMA/Beclin1
signaling pathway in METH-induced endothelial cell apoptosis. Briefly, Nupr1
expression is increased following METH treatment. Increased Nupr1 upregulates the
expression of Chop. As a transcription factor, Chop upregulates the expression of
P53, and P53 raises up PUMA expression, which mediates the mitochondrial
apoptosis pathway by changing the ratio of Bax/Bcl-2. Meanwhile, Chop also
increases the expression of Beclin1, which forms th eBcl-2/Beclin1 complex, thereby
decreasing the dissociative Bcl-2. As a result, the ratio of dissociative Bcl-2 to Bax is
also significantly decreased. The increased ratio of Bax/Bcl-2 results in translocation
of cyto c, an apoptogenic factor, from the mitochondria to cytoplasm and activation of
caspase-dependent apoptotic pathways
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METH (1.25 mM for HUVECs and 0.5 mM for CMECs) for 24 h. Cells were
centrifuged to remove the medium, washed twice with 4 °C PBS, and stained with
Annexin V-FITC and propidiumiodide (Keygen, Nanjing, China) according to the
Annexin V apoptosis detection kit instructions. The percentage of apoptotic cells was
quantified using a flow cytometry system (FACSCalibur; BD Biosciences, San Jose,
CA, USA).
TUNEL staining. HUVECs and CMECs (5 × 105/well) were exposed to METH
(1.25 mM for HUVECs and 0.5 mM for CMECs) for 24 h. DNA fragmentation was
visualized using a fluorometric TUNEL system for apoptotic cells (Roche Applied
Science, Indianapolis, IN, USA) according to the manufacturer’s instructions. Briefly,
HUVECs and CMECs were fixed in 4% paraformaldehyde in ice-cold PBS (pH7.4)
at room temperature for 15 min, incubated with fluorescein-conjugated TdT enzyme
at 37 °C for 1 h in the dark and then mounted with DAPI for nuclear counter
staining. For frozen tissues, 5 μm tissue sections were sliced using a freezing
microtome (CM1900; Leica, Wetzlar, Germany). The tissue sections were placed on
a Fisher Superfrost slide and dried overnight at room temperature (RT). The slides
were fixed by immersion in cold acetone (−20 °C) for 2 min and then air-dried at
RT. The pretreatment of tissue sections (including deparaffinizing, rehydration,
retrieval with reconstituted proteinase K, equilibration and slide washing) were
performed according to the manufacturer’s instructions. Tissue slides were
incubated with Nucleotide Mix and rTdT buffer solution at 37 °C for 60 min to
allow sufficient reaction. The reaction was terminated by adding 2 × SSC solution (a
concentrated solution of sodium chloride–sodium citrate in distilled/deionized water),
followed by 15 min incubation. The control incubation buffer was prepared without
the rTdT enzyme; all other steps were similar. Samples were stained with DAPI to
determine the total number of nuclei. Cross-sections were photographed (×20 and
× 40 objectives) using a fluorescence microscope (ECLIPSE 80i; Nikon). Both
TUNEL- and DAPI-positive cells were counted. Data are presented as the TUNEL
index, which was calculated based on the total number of TUNEL-positive cells.
Measurement of mitochondrial membrane potential. The mitochon-
drial membrane potential was determined using JC-1 kit (C2006; Beyotime, Haimen,
China). HUVECs were seeded (2 × 105 cells/well) in six-well culture plates. After
24 h exposure with vehicle or METH (1.25 mM), the supernatant was removed and
cells were washed with PBS and then maintained in JC-1-containing DMEM
medium for 20 min at 37 °C in the dark. Thereafter, cells were washed twice with
buffer solution (4 °C) and analyzed with flow cytofluorometry.
Double immunofluorescence labeling. To determine Nupr1 expression
level in cardiac endothelial cells, we performed double immunofluorescence labeling
on frozen sections of adult rat hearts as described before.51 For immunolabeling, all
incubation solutions were prepared using PBS supplemented with 10% normal goat
serum and 0.05% Triton X-100. The antibodies used were CD31 (mouse, 1:100;
Santa Cruz), Nupr1 (rabbit, 1:100; Santa Cruz), fluorescein (FITC)-conjugated
rabbit anti-mouse IgG (1:50; DingGuo), fluorescein (Cy3)-conjugated sheep anti-
rabbit IgG (1:50; DingGuo). These antibodies were used together with DAPI nuclear
labeling. The frozen tissue sections were incubated with blocking buffer (5% skim
milk) for 30 min at RT, with the primary antibody overnight at 4 °C, and then with the
secondary antibody for 1 h at RT. Microphotographs were taken using fluorescence
microscopy (A1+/A1R+; Nikon). All digital images were processed using the same
settings to improve the contrast.
siRNA and transfection. siRNA sequences that target Nupr1 (2 pieces),
Chop (4 pieces), P53 (4 pieces), Puma (4 pieces) or Beclin1 (4 pieces) were
designed by Shanghai GenePharma Co. Ltd (Shanghai, China), as shown below:
siNupr1#1 (Human, 5′-CAGACAAAGCGUUAGGAGA-3′), siNupr1#2 (Human, 5′-
CAGAGACAGACAAAGCGUU-3′), siChop#1 (Human, 5′-GGGAUACCAUGCAACA
UAA-3′), siChop#2 (Human, 5′-CUAGAAAUCUGUUGCUAUG-3′), siChop #3 (Rats,
5′-CCTGTCCTCAGATGAAATT-3′), siChop #4 (Rats, 5′-CCAGATTCCAGTCAG
AGTT-3′), siP53 #1 (Human, 5′-UCAAAUCAUCCAUUGCUTT-3′), siP53 #2
(Human, 5′-UUACAUCUCCCAAACAUTT-3′), siP53 #3 (Rat, 5′-UACAUUAUUUCA
UUAAATT -3′), siP53 #4 (Rat, 5′-AAAACCUUAAAAUCUAATT-3′), siPuma #1
(Human, 5′-GGGUCCUGUACAAUCUCAUTT-3′), siPuma #2 (Human, 5′-CGAGA
UGGAGCCCAAUUAGTT-3′), siPuma #3 (Rat, 5′-GCGGAGACAAGAAGAGCAATT
-3′), siPuma #4 (Rat, 5′-GUCAUGUAUAAUCUCUUCATT-3′), siBeclin1 #1 (Human,
5′-CUGGACACGAGUUUCAAGATT-3′), siBeclin1 #2 (Human, 5′-GUGGAAUG
GAAUGAGAUUATT-3′), siBeclin1 #3 (Rat, 5′-CAGGAGAGGAGCCAUUUAUTT
-3′), siBeclin1 #4 (Rat, 5′-GUCCCUGACAGACAAAUCUTT-3′), siRNAs were
dissolved in DEPC water at a concentration of 20 μM. siRNA transfection was
performed according to the instructions of Lipofectamine 2000 Transfection Reagent
kit from Invitrogen. Briefly, the siRNA for each gene of interest and the
corresponding control siRNA were separately mixed with Lipofectamine 2000,
vortexed for 20 s, and then incubated at RT for 30 min prior to use. HUVECs and
CMECs were seeded on six-well plates at a density of 2 × 106/well. siRNA mixture
was added gently and slowly, and then 1 ml complete medium was added in each
well. After 6 h incubation, all supernatant was discarded and then 2 ml complete
medium was added in each well.
Lentivirus production and infection of CMECs cell. The shRNA
synthesis was based on a previous study.5 Briefly, the shRNA sequence targeting
Nupr1 (5′-GCAACCTGTAAACATAGAG-3′ and 5′-GCCTGGCCCAATCTTATGT-3′)
was cloned into pGC-LV vector. pGC-LV-shNupr1, pHelper 1.0, and pHelper 2.0
were cotransfected into HEK293FT cells. LV-shNupr1 was harvested with 1 × 109
transducing units per milliliter and LV-GFP was used as the reference control virus.
Viral supernatants were collected at 72 h, centrifuged at 4500 × g for 5 min, filtered
through a 0.22 μm filter, and incubated with CMECs and polybrene (5 μg/ml). After
24 h of viral transduction, cells were given fresh growth media and the cells were
passaged when they reached the exponential phase.
Co-immunoprecipitation assay and immunoblotting analysis.
After exposure to METH (1.25 mM for HUVECs and 0.5 mM for CMECs) or vehicle for
24 h, cells were washed with ice-cold lysis buffer containing protease inhibitor mix
(Sigma). The lysates were incubated with Beclin1 antibody for 1 h and then with protein
A/G-agarose beads at 4 °C for 12 h. The immunoprecipitates were pelleted, washed
and subjected to immunoblotting using Bcl-2 or Beclin1 antibody as described above.
Statistical analysis. Data given in the text are expressed as mean±
standard deviation (S.D.) of at least three independent replicates. Statistical analysis
was performed using one-way ANOVA followed by LSD post hoc analysis or
independent-samples t-test (as appropriate) using the scientific statistic software
SPSS version 19.0 (SPSS Inc., Chicago, IL, USA). The value of Po0.05 was
considered statistically significant.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. This work was supported by the Natural Science
Foundation of China (Grant no. 81430045 and no. 81370227).
1. Kiyatkin EA, Sharma HS. Acute methamphetamine intoxication: brain hyperthermia, blood-
brain barrier, brain edema, and morphological cell abnormalities. Int Rev Neurobiol 2009; 88:
65–100.
2. Mendelson J, Jones RT, Upton R, Jacob P III. Methamphetamine and ethanol interactions
in humans. Clin Pharmacol Ther 1995; 57: 559–568.
3. Chen R, Wang B, Chen L, Cai D, Li B, Chen C et al. DNA damage-inducible transcript 4
(DDIT4) mediates methamphetamine-induced autophagy and apoptosis through mTOR
signaling pathway in cardiomyocytes. Toxicol Appl Pharmacol 2016; 295: 1–11.
4. Li B, Chen R, Chen L, Qiu P, Ai X, Huang E et al. Effects of DDIT4 in methamphetamine-
induced autophagy and apoptosis in dopaminergic neurons. Mol Neurobiol 2016
(doi:10.1007/s12035-015-9637-9).
5. Huang W, Qiao D, Qiu P, Huang E, Li B, Chen C et al. Caspase-11 plays an essential role in
methamphetamine-induced dopaminergic neuron apoptosis. Toxicol Sci 2015; 145: 68–79.
6. Yeo KK, Wijetunga M, Ito H, Efird JT, Tay K, Seto TB et al. The association of metham-
phetamine use and cardiomyopathy in young patients. Am J Med 2007; 120: 165–171.
7. Sadeghi R, Agin K, Taherkhani M, Najm-Afshar L, Nelson LS, Abdollahi M et al. Report of
methamphetamine use and cardiomyopathy in three patients. Daru 2012; 20: 20.
8. Islam MN, Kuroki H, Hongcheng B, Ogura Y, Kawaguchi N, Onishi S et al. Cardiac lesions
and their reversibility after long term administration of methamphetamine. Forensic Sci Int
1995; 75: 29–43.
9. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco:
demographic, pathologic, and toxicologic profiles. J Forensic Sci 1999; 44: 359–368.
10. Turnipseed SD, Richards JR, Kirk JD, Diercks DB, Amsterdam EA. Frequency of acute
coronary syndrome in patients presenting to the emergency department with chest pain after
methamphetamine use. J Emerg Med 2003; 24: 369–373.
11. Ma J, Wan J, Meng J, Banerjee S, Ramakrishnan S, Roy S. Methamphetamine induces
autophagy as a pro-survival response against apoptotic endothelial cell death through the
Kappa opioid receptor. Cell Death Dis 2014; 5: e1099.
Nupr1/Chop and METH-induced EC apoptosis
D Cai et al
13
Cell Death and Disease
12. Rosas-Hernandez H, Cuevas E, Lantz-McPeak SM, Ali SF, Gonzalez C. Prolactin protects
against the methamphetamine-induced cerebral vascular toxicity. Curr Neurovasc Res 2013;
10: 346–355.
13. Shao X, Hu Z, Hu C, Bu Q, Yan G, Deng P et al. Taurine protects methamphetamine-induced
developmental angiogenesis defect through antioxidant mechanism. Toxicol Appl Pharmacol
2012; 260: 260–270.
14. Liu J, Wang P, Xue YX, Li Z, Qu CB, Liu YH. Enhanced antitumor effect of shikonin by
inhibiting endoplasmic reticulum stress via JNK/c-Jun pathway in human glioblastoma
stem cells. Biochem Biophys Res Commun 2015; 466: 103–110.
15. Senft D, Ronai ZA. UPR, autophagy, and mitochondria crosstalk underlies the ER stress
response. Trends Biochem Sci 2015; 40: 141–148.
16. Zhang M, Guo Y, Fu H, Hu S, Pan J, Wang Y et al. Chop deficiency prevents UUO-induced
renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFkappaB/
IL-1beta signaling. Cell Death Dis 2015; 6: e1847.
17. Ding X, Ma M, Teng J, Wu E, Wang X. Numb protects human renal tubular epithelial cells
from bovine serum albumin-induced apoptosis through antagonizing CHOP/PERK pathway.
J Cell Biochem 2015; 117: 163–171.
18. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell
Death Differ 2004; 11: 381–389.
19. Liu Y, Liu JH, Chai K, Tashiro S, Onodera S, Ikejima T. Inhibition of c-Met promoted
apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-
induced A549 lung cancer cells. J Pharm Pharmacol 2013; 65: 1622–1642.
20. Khalyfa A, Chlon T, Qiang H, Agarwal N, Cooper NG. Microarray reveals complement
components are regulated in the serum-deprived rat retinal ganglion cell line. Mol Vis 2007;
13: 293–308.
21. Palam LR, Gore J, Craven KE, Wilson JL, Korc M. Integrated stress response is
critical for gemcitabine resistance in pancreatic ductal adenocarcinoma. Cell Death Dis 2015;
6: e1913.
22. Chowdhury UR, Samant RS, Fodstad O, Shevde LA. Emerging role of nuclear protein 1
(NUPR1) in cancer biology. Cancer Metastasis Rev 2009; 28: 225–232.
23. Clark DW, Mitra A, Fillmore RA, Jiang WG, Samant RS, Fodstad O et al.
NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial
cells from doxorubicin-induced genotoxic stress. Curr Cancer Drug Targets 2008; 8:
421–430.
24. Guo X, Wang W, Hu J, Feng K, Pan Y, Zhang L et al. Lentivirus-mediated RNAi knockdown
of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo. Anat Rec
2012; 295: 2114–2121.
25. Hamidi T, Algul H, Cano CE, Sandi MJ, Molejon MI, Riemann M et al. Nuclear protein 1
promotes pancreatic cancer development and protects cells from stress by inhibiting
apoptosis. J Clin Invest 2012; 122: 2092–2103.
26. Lorente M, Carracedo A, Torres S, Natali F, Egia A, Hernandez-Tiedra S et al. Amphiregulin
is a factor for resistance of glioma cells to cannabinoid-induced apoptosis. Glia 2009; 57:
1374–1385.
27. Ai ZB, Li CY, Li LT, He GH. Resveratrol inhibits beta-amyloid-induced neuronal
apoptosis via regulation of p53 acetylation in PC12 cells. Mol Med Rep 2015; 11:
2429–2434.
28. Akhter R, Sanphui P, Das H, Saha P, Biswas SC. The regulation of p53 up-regulated
modulator of apoptosis by JNK/c-Jun pathway in beta-amyloid-induced neuron death.
J Neurochem 2015; 134: 1091–1103.
29. Tang YL, Huang LB, Tian Y, Wang LN, Zhang XL, Ke ZY et al. Flavokawain B inhibits the
growth of acute lymphoblastic leukemia cells via p53 and caspase-dependent mechanisms.
Leuk Lymph 2015; 56: 2398–2407.
30. Hockings C, Anwari K, Ninnis RL, Brouwer J, O'Hely M, Evangelista M et al. Bid chimeras
indicate that most BH3-only proteins can directly activate Bak and Bax, and show no
preference for Bak versus Bax. Cell Death Dis 2015; 6: e1735.
31. Zhao JJ, Chu ZB, Hu Y, Lin J, Wang Z, Jiang M et al. Targeting the miR-221-222/PUMA/BAK/
BAX pathway abrogates dexamethasone resistance in multiple myeloma. Cancer Res 2015;
75: 4384–4397.
32. Martins T, Burgoyne T, Kenny BA, Hudson N, Futter CE, Ambrosio AF et al.
Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier
endothelial cells. Neuropharmacology 2013; 65: 74–82.
33. Deng X, Cai NS, McCoy MT, Chen W, Trush MA, Cadet JL. Methamphetamine induces
apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death
pathway. Neuropharmacology 2002; 42: 837–845.
34. Kong DK, Georgescu SP, Cano C, Aronovitz MJ, Iovanna JL, Patten RD et al. Deficiency of
the transcriptional regulator p8 results in increased autophagy and apoptosis, and causes
impaired heart function. Mol Biol Cell 2010; 21: 1335–1349.
35. Baryakin DN, Semenov DV, Savelyeva AV, Koval OA, Rabinov IV, Kuligina EV et al.
Alu- and 7SL RNA analogues suppress MCF-7 cell viability through modulating the
transcription of endoplasmic reticulum stress response genes. Acta Naturae 2013; 5: 83–93.
36. Cao S, Yan B, Lu Y, Zhang G, Li J, Guo W et al. C/EBP homologous protein-mediated
endoplasmic reticulum stress-related renal apoptosis is involved in rats with brain death.
Transplant Proc 2015; 47: 354–358.
37. Kang JS. Exercise copes with prolonged stress-induced impairment of spatial memory
performance by endoplasmic reticulum stress. J Exerc Nutr Biochem 2015 Nov 2. pii:3347.
38. Kim JO, Kwon EJ, Song DW, Lee JS, Kim DH. miR-185 inhibits endoplasmic reticulum
stress-induced apoptosis by targeting Na+/H+ exchanger-1 in the heart. BMB Rep 2015
(e-pub ahead of print).
39. Ghosh AP, Klocke BJ, Ballestas ME, Roth KA. CHOP potentially co-operates with FOXO3a
in neuronal cells to regulate PUMA and BIM expression in response to ER stress. PLoS One
2012; 7: e39586.
40. Rizzi F, Naponelli V, Silva A, Modernelli A, Ramazzina I, Bonacini M et al. Polyphenon E(R),
a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of
immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis. Carcinogenesis
2014; 35: 828–839.
41. Wali JA, Rondas D, McKenzie MD, Zhao Y, Elkerbout L, Fynch S et al. The proapoptotic
BH3-only proteins Bim and Puma are downstream of endoplasmic reticulum and
mitochondrial oxidative stress in pancreatic islets in response to glucotoxicity. Cell Death
Dis 2014; 5: e1124.
42. Chen C, Qincao L, Xu J, Du S, Huang E, Liu C et al. Role of PUMA in methamphetamine-
induced neuronal apoptosis. Toxicol Lett 2016; 240: 149–160.
43. Ciechomska IA, Goemans GC, Skepper JN, Tolkovsky AM. Bcl-2 complexed with Beclin-1
maintains full anti-apoptotic function. Oncogene 2009; 28: 2128–2141.
44. Ciechomska IA, Goemans CG, Tolkovsky AM. Why doesn't Beclin 1, a BH3-only protein,
suppress the anti-apoptotic function of Bcl-2? Autophagy 2009; 5: 880–881.
45. Cadet JL, Jayanthi S, Deng X. Speed kills: cellular and molecular bases of metham-
phetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J 2003;
17: 1775–1788.
46. Krasnova IN, Cadet JL. Methamphetamine toxicity and messengers of death. Brain Res Rev
2009; 60: 379–407.
47. Qiao D, Xu J, Le C, Huang E, Liu C, Qiu P et al. Insulin-like growth factor binding protein 5
(IGFBP5) mediates methamphetamine-induced dopaminergic neuron apoptosis. Toxicol Lett
2014; 230: 444–453.
48. Balligand JL, Ungureanu-Longrois D, Simmons WW, Kobzik L, Lowenstein CJ, Lamas S
et al. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and
IFN-gamma. Am J Physiol 1995; 268: H1293–H1303.
49. Nishida M, Carley WW, Gerritsen ME, Ellingsen O, Kelly RA, Smith TW. Isolation and
characterization of human and rat cardiac microvascular endothelial cells. Am J Physiol
1993; 264: H639–H652.
50. Zhang L, Ding K, Wang H, Wu Y, Xu J. Traumatic brain injury-induced neuronal apoptosis is
reduced through modulation of PI3K and autophagy pathways in mouse by FTY720. Cell Mol
Neurobiol 2015; 36: 131–142.
51. Zhou X, Chen X, Cai JJ, Chen LZ, Gong YS, Wang LX et al. Relaxin inhibits cardiac fibrosis
and endothelial-mesenchymal transition via the Notch pathway. Drug Des Dev Ther 2015; 9:
4599–4611.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under a Creative Commons Attribution 4.0 International
License. The images or other third party material in this article are
included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the
Creative Commons license, users will need to obtain permission from
the license holder to reproduce the material. To view a copy of this
license, visit http://creativecommons.org/licenses/by/4.0/
Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)
Nupr1/Chop and METH-induced EC apoptosis
D Cai et al
14
Cell Death and Disease
